Biliary tract cancer
Søreide, Kjetil ; Dopazo, Cristina ; Berrevoet, Frederik ; Carrion-Alvarez, Lucia ; Diaz-Nieto, Rafael ; Andersson, Bodil LU
and Stättner, Stefan
(2024)
In European Journal of Surgical Oncology
- Abstract
Background: Biliary tract cancers comprise a heterogeneous collection of malignancies usually described as cholangiocarcinoma of the intra- or extrahepatic bile duct, including perihilar cholangiocarcinoma and gallbladder cancer. Methods: A review of pertinent parts of the ESSO core curriculum for the UEMS diploma targets (Fellowships exam, EBSQ), based on updated and available guidelines for diagnosis, surgical treatment and oncological management of cholangiocarcinoma. Results: Following the outline from the ESSO core curriculum we present the epidemiology and risk factors for cholangiocarcinoma, as well as the rationale for the current diagnosis, staging, (neo-)adjuvant treatment, surgical management, and short- and long-term... (More)
Background: Biliary tract cancers comprise a heterogeneous collection of malignancies usually described as cholangiocarcinoma of the intra- or extrahepatic bile duct, including perihilar cholangiocarcinoma and gallbladder cancer. Methods: A review of pertinent parts of the ESSO core curriculum for the UEMS diploma targets (Fellowships exam, EBSQ), based on updated and available guidelines for diagnosis, surgical treatment and oncological management of cholangiocarcinoma. Results: Following the outline from the ESSO core curriculum we present the epidemiology and risk factors for cholangiocarcinoma, as well as the rationale for the current diagnosis, staging, (neo-)adjuvant treatment, surgical management, and short- and long-term outcomes. The available guidelines and consensus reports (i.e. NCCN, BGS and ESMO guidelines) are referred to. Recognition of biliary tract cancers as separate entities of the intrahepatic biliary ducts, the perihilar and distal bile duct as well as the gallbladder is important for proper management, as they each provide distinct clinical, molecular and treatment profiles to consider. Conclusion: Core competencies in knowledge to the diagnosis, management and outcomes of biliary tract cancers are presented.
(Less)
- author
- Søreide, Kjetil
; Dopazo, Cristina
; Berrevoet, Frederik
; Carrion-Alvarez, Lucia
; Diaz-Nieto, Rafael
; Andersson, Bodil
LU
and Stättner, Stefan
- author collaboration
- organization
- publishing date
- 2024
- type
- Contribution to journal
- publication status
- epub
- subject
- keywords
- Bile duct cancer, Chemotherapy, Cholangiocarinoma, Intrahepatic, Liver, Liver surgery, Perihilar
- in
- European Journal of Surgical Oncology
- article number
- 108489
- publisher
- Elsevier
- external identifiers
-
- scopus:85196408780
- pmid:38266282
- ISSN
- 0748-7983
- DOI
- 10.1016/j.ejso.2024.108489
- language
- English
- LU publication?
- yes
- id
- 6890b139-16c0-4e39-a44b-6f1fb4f3292e
- date added to LUP
- 2024-09-11 14:28:12
- date last changed
- 2025-01-30 08:52:00
@article{6890b139-16c0-4e39-a44b-6f1fb4f3292e,
abstract = {{<p>Background: Biliary tract cancers comprise a heterogeneous collection of malignancies usually described as cholangiocarcinoma of the intra- or extrahepatic bile duct, including perihilar cholangiocarcinoma and gallbladder cancer. Methods: A review of pertinent parts of the ESSO core curriculum for the UEMS diploma targets (Fellowships exam, EBSQ), based on updated and available guidelines for diagnosis, surgical treatment and oncological management of cholangiocarcinoma. Results: Following the outline from the ESSO core curriculum we present the epidemiology and risk factors for cholangiocarcinoma, as well as the rationale for the current diagnosis, staging, (neo-)adjuvant treatment, surgical management, and short- and long-term outcomes. The available guidelines and consensus reports (i.e. NCCN, BGS and ESMO guidelines) are referred to. Recognition of biliary tract cancers as separate entities of the intrahepatic biliary ducts, the perihilar and distal bile duct as well as the gallbladder is important for proper management, as they each provide distinct clinical, molecular and treatment profiles to consider. Conclusion: Core competencies in knowledge to the diagnosis, management and outcomes of biliary tract cancers are presented.</p>}},
author = {{Søreide, Kjetil and Dopazo, Cristina and Berrevoet, Frederik and Carrion-Alvarez, Lucia and Diaz-Nieto, Rafael and Andersson, Bodil and Stättner, Stefan}},
issn = {{0748-7983}},
keywords = {{Bile duct cancer; Chemotherapy; Cholangiocarinoma; Intrahepatic; Liver; Liver surgery; Perihilar}},
language = {{eng}},
publisher = {{Elsevier}},
series = {{European Journal of Surgical Oncology}},
title = {{Biliary tract cancer}},
url = {{http://dx.doi.org/10.1016/j.ejso.2024.108489}},
doi = {{10.1016/j.ejso.2024.108489}},
year = {{2024}},
}